RecruitingNCT05537454

Maternal Stress, Milk Composition, and Preterm Neurodevelopment

Maternal Stress, Human Milk Composition, and Neurodevelopmental and Feeding Outcomes


Sponsor

University of Minnesota

Enrollment

120 participants

Start Date

Dec 9, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This study explores the associations between maternal stress, breastmilk composition, and feeding and neurodevelopment for preterm infants in the NICU and at 4 months corrected age.


Eligibility

Min Age: 28 WeeksMax Age: 34 Weeks

Inclusion Criteria2

  • preterm infant born between 28 0/7 and 34 6/7 weeks' gestation that are medically stable for study procedures
  • mother of preterm infant meeting criteria and a) 18 to 45 years of age at the time of delivery

Exclusion Criteria2

  • infants: major congenital anomalies, anticipated death, positive blood culture at birth, hypoxic ischemic encephalopathy, grade IV intraventricular hemorrhage, or plan to transfer care before discharge (35-37 weeks postmenstrual age).
  • mothers: a) alcohol consumption \>1 drink per week or any tobacco consumption during pregnancy, b) known congenital metabolic, endocrine disease or congenital illness affecting infant feeding/growth

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05537454


Related Trials